OS Therapies Inc (OSTX): Next-Year EPS Estimate 85.16%
As of 2026-06-04, OS Therapies Inc (OSTX) has a next-year EPS growth estimate of 85.16%.
On 2026-05-24, analyst consensus for OSTX's next-year EPS growth shifted from 66.61% to 85.16% — a positive change of 18.55 percentage points. The revised estimate has been sustained across 10 subsequent trading sessions. Current-year growth is projected at 34.69%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 85.16%
- EPS growth this year
- 34.69%
- EPS next quarter (est)
- -$0.14
- Last price
- $1.85
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 85.16% | 34.69% | -$0.14 | $1.85 |
| 2026-06-03 | 85.16% | 34.69% | -$0.14 | $1.80 |
| 2026-06-02 | 85.16% | 34.69% | -$0.14 | $1.83 |
| 2026-06-01 | 85.16% | 34.69% | -$0.14 | $1.87 |
| 2026-05-31 | 85.16% | 34.69% | -$0.14 | $2.14 |
| 2026-05-28 | 85.16% | 34.69% | -$0.14 | $1.98 |
| 2026-05-27 | 85.16% | 34.69% | -$0.14 | $1.89 |
| 2026-05-26 | 85.16% | 34.69% | -$0.14 | $1.75 |
| 2026-05-25 | 85.16% | 34.69% | -$0.14 | $1.73 |
| 2026-05-24 | 85.16% | 34.69% | -$0.14 | $1.73 |
| 2026-05-21 | 66.61% | 38.27% | -$0.15 | $1.82 |
| 2026-05-20 | 66.61% | 38.27% | -$0.15 | $1.83 |
| 2026-05-19 | 66.61% | 38.27% | -$0.15 | $1.76 |
| 2026-05-18 | 66.47% | 38.52% | -$0.17 | $1.73 |
| 2026-05-17 | 66.47% | 38.52% | -$0.17 | $1.88 |
| 2026-05-14 | 66.47% | 38.52% | -$0.17 | $1.88 |
| 2026-05-13 | 66.47% | 38.52% | -$0.17 | $1.76 |
| 2026-05-12 | 57.26% | 38.52% | -$0.18 | $1.71 |
| 2026-05-11 | 57.26% | 38.52% | -$0.18 | $1.71 |
| 2026-05-10 | 57.26% | 38.52% | -$0.18 | $1.66 |
| 2026-05-07 | 57.26% | 38.52% | -$0.18 | $1.70 |
| 2026-05-06 | 57.26% | 38.52% | -$0.18 | $1.73 |
| 2026-05-05 | 57.26% | 38.52% | -$0.18 | $1.73 |
| 2026-05-04 | 57.26% | 38.52% | -$0.18 | $1.66 |
| 2026-05-03 | 57.26% | 38.52% | -$0.18 | $1.61 |
| 2026-04-30 | 44.83% | 40.82% | -$0.18 | $1.70 |
| 2026-04-29 | 44.83% | 40.82% | -$0.18 | $1.63 |
| 2026-04-28 | 44.83% | 40.82% | -$0.18 | $1.63 |
| 2026-04-27 | 44.83% | 40.82% | -$0.18 | $1.77 |
| 2026-04-26 | 44.83% | 40.82% | -$0.18 | $1.77 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is OS Therapies Inc's next-year EPS growth estimate?▾
As of 2026-06-04, OS Therapies Inc (OSTX) has a next-year EPS growth estimate of 85.16%, based on analyst consensus.
When was the latest EPS estimate revision for OSTX?▾
The most recent revision occurred on 2026-05-24, when analysts adjusted the next-year EPS growth estimate from 66.61% to 85.16%.
What sector and industry does OS Therapies Inc belong to?▾
OS Therapies Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. OSTX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. OS Therapies Inc (OSTX) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports